Instillido

Lidocaine, the active ingredient in Instillido, is a local anesthetic presented as a sterile solution for urethral use. It provides localized numbness to facilitate diagnostic and therapeutic urologic procedures.\n\nGNH India supplies Instillido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Instillido is a lidocaine‑based local anesthetic used via the urethral route to achieve temporary loss of sensation during urologic interventions.\n\nUrethral anesthesia for diagnostic procedures: provides localized numbness to facilitate cystoscopy and similar examinations.\nUrethral anesthesia for therapeutic procedures: enables pain‑free catheter placement and minor interventions.\nUrethral anesthesia for minor urologic surgeries: reduces discomfort during short surgical manipulations.

Common Side Effects:\n- Burning sensation at the application site\n- Mild irritation of urethral mucosa\n- Transient urinary urgency\n- Temporary numbness lasting a few hours\n- Mild headache\n\nSerious or Rare Side Effects:\n- Allergic reaction (rash, angioedema, anaphylaxis)\n- Severe systemic toxicity (CNS disturbances such as seizures, cardiac arrhythmias)\n- Persistent numbness beyond expected duration\n- Hypotension or cardiovascular collapse\n- Respiratory depression in extreme cases

Before using Instillido, consider the following precautions:\n- Allergy assessment: verify no known hypersensitivity to lidocaine or amide‑type anesthetics.\n- Dosage determination: follow prescriber instructions based on procedure type and patient characteristics.\n- Systemic absorption: monitor for signs of toxicity, especially in patients with hepatic impairment.\n- Concurrent anesthetics: avoid using other local anesthetics simultaneously to prevent additive toxicity.\n- Pregnancy and lactation: use only if benefits outweigh potential risks.\n- Store at room temperature: keep in original container, protect from moisture and light.

Major Interactions (Avoid):\n- Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase lidocaine toxicity.\n- Strong CYP3A4 inhibitors (e.g., ketoconazole): raise systemic lidocaine levels.\n- Other local anesthetics: additive neuro‑ and cardiotoxic effects.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: may mask early signs of lidocaine toxicity.\n- Diuretics: can alter plasma concentration of lidocaine.\n- General anesthetics: synergistic CNS depression when used together.